Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Virol
1992 Nov 01;6611:6769-72. doi: 10.1128/JVI.66.11.6769-6772.1992.
Show Gene links
Show Anatomy links
An adenosine at position 27 in the human immunodeficiency virus type 1 trans-activation response element is not critical for transcriptional or translational activation by Tat.
Blanchard AD
,
Powell R
,
Braddock M
,
Kingsman AJ
,
Kingsman SM
.
???displayArticle.abstract???
Tat protein binds to the trans-activation response (TAR) element of human immunodeficiency virus type 1 RNAs and activates gene expression at the level of transcription in mammalian cell lines and translation in Xenopus oocytes. Certain residues within TAR are important for Tat binding in vitro, including residue A-27, which appears to be able to be modified in a Tat-dependent manner in Xenopus oocytes (L. Sharmeen, B. Bass, N. Sonenberg, H. Weintraub, and M. Groudine, Proc. Natl. Acad. Sci. USA 88:8096-8100, 1991). Activation by Tat in oocytes occurs via a covalent modification of TAR-containing RNA. We have found that in both mammalian cells and Xenopus oocytes, conversion of A-27.U-38 or C-27.G-38 or C-27.G-38 reduces activation. However, conversion to G-27.U-38 or G-27.C-38 had little or no effect on activation, and in oocytes, these mutant RNAs were still covalently modified. These data exclude a specific role for the adenosine at residue 27 for Tat activation but suggest a requirement for a purine at this position.
Adams,
Synthesis of a gene for the HIV transactivator protein TAT by a novel single stranded approach involving in vivo gap repair.
1988, Pubmed
Adams,
Synthesis of a gene for the HIV transactivator protein TAT by a novel single stranded approach involving in vivo gap repair.
1988,
Pubmed
Bass,
An unwinding activity that covalently modifies its double-stranded RNA substrate.
1988,
Pubmed
,
Xenbase
Berkhout,
Detailed mutational analysis of TAR RNA: critical spacing between the bulge and loop recognition domains.
1991,
Pubmed
Berkhout,
trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: a quantitative analysis.
1989,
Pubmed
Braddock,
Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity.
1991,
Pubmed
,
Xenbase
Braddock,
A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interaction.
1990,
Pubmed
,
Xenbase
Braddock,
HIV-1 TAT "activates" presynthesized RNA in the nucleus.
1989,
Pubmed
,
Xenbase
Cordingley,
Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.
1990,
Pubmed
Cullen,
Regulatory pathways governing HIV-1 replication.
1989,
Pubmed
Dingwall,
HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure.
1990,
Pubmed
Gaynor,
Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region.
1989,
Pubmed
Hauber,
Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat.
1988,
Pubmed
Jakobovits,
A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator.
1988,
Pubmed
Johnston,
Autoradiography using storage phosphor technology.
1990,
Pubmed
Marciniak,
Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus.
1990,
Pubmed
Muesing,
Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein.
1987,
Pubmed
Nishikura,
Substrate specificity of the dsRNA unwinding/modifying activity.
1991,
Pubmed
Rosen,
The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.
1985,
Pubmed
Roy,
A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.
1990,
Pubmed
Roy,
Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence.
1990,
Pubmed
Seeman,
Sequence-specific recognition of double helical nucleic acids by proteins.
1976,
Pubmed
Selby,
Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat.
1989,
Pubmed
Sharmeen,
Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA.
1991,
Pubmed
,
Xenbase
Sheline,
Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin.
1991,
Pubmed
Sowden,
Multiple cooperative interactions constrain BPV-1 E2 dependent activation of transcription.
1989,
Pubmed
Sugimoto,
Energetics of internal GU mismatches in ribooligonucleotide helixes.
1986,
Pubmed
Sumner-Smith,
Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein.
1991,
Pubmed
Turner,
RNA structure prediction.
1988,
Pubmed
Wagner,
Double-stranded RNA unwinding and modifying activity is detected ubiquitously in primary tissues and cell lines.
1990,
Pubmed
,
Xenbase
Weeks,
Fragments of the HIV-1 Tat protein specifically bind TAR RNA.
1990,
Pubmed
Weeks,
RNA recognition by Tat-derived peptides: interaction in the major groove?
1991,
Pubmed